A detailed history of Logos Global Management LP transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Logos Global Management LP holds 600,000 shares of APLT stock, worth $5.96 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
600,000
Previous 600,000 -0.0%
Holding current value
$5.96 Million
Previous $2.8 Million -0.0%
% of portfolio
0.26%
Previous 0.26%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$4.04 - $6.37 $3.03 Million - $4.78 Million
-750,000 Reduced 55.56%
600,000 $2.8 Million
Q1 2024

May 15, 2024

SELL
$2.25 - $7.4 $697,500 - $2.29 Million
-310,000 Reduced 18.67%
1,350,000 $9.18 Million
Q4 2023

Feb 14, 2024

BUY
$1.84 - $3.35 $3.05 Million - $5.56 Million
1,660,000 New
1,660,000 $5.56 Million
Q3 2020

Nov 16, 2020

SELL
$19.43 - $35.36 $244,818 - $445,536
-12,600 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$29.41 - $51.23 $370,566 - $645,498
12,600 New
12,600 $455,000

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $477M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.